Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

DOI: 10.1186/s40035-018-0137-5

Keywords: Parkinson’s disease, Monoamine oxidase inhibitor, Rasagiline, Monotherapy, China

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s40035-018-0137-5) contains supplementary material, which is available to authorized users

Full-Text